- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05067673
Tissue Changes in Lumbar Multifidus After Dry Needling in Subjects With Nonspecific Low Back Pain.
Association Between Tissue Changes in Lumbar Multifidae and Improvement in Pain and Disability After Dry Needling in Subjects With Nonspecific Low Back Pain. Randomized Clinical Trial.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Lower back pain in regarded as the main cause of disability in the world, which has a significant socio-economic impact. Deep dry needling is effective in handling such pain and is one of the techniques of choice by physiotherapists. In this area, the use of ultrasound provides information of interest such as length, thickness, diameter, cross-sectional area or muscle volume, among others.
Objective: Finding out if tissue changes (thickness, histogram and shrinkage rate) that occur in the lumbar multifidus after deep dry needling are related to changes in patient's pain and disability.
It's a double-blind randomized clinical trial in parallel groups. Patients will be randomly divided into 2 groups. One of them will receive dry needling and the other dry needling placebo. The initial, post-needling and a week after evaluations will be performed by a blinded to the intervention therapist.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Madrid
-
Torrejón De Ardoz, Madrid, Spania, 28850
- Sebastian
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age between 18 and 65 years.
- Nonspecific pain in the lumbar region.
Exclusion Criteria:
- Previous surgery in the lumbosacral spine.
- Osteoporosis.
- Needle phobia.
- Neurogenic pain with positive tests or negative symptoms.
- Red flags: cauda equina syndrome, sudden weight loss, fracture, cancer, infection or systemic diseases.
- Pregnancy.
- Physiotherapy intervention in the 4 weeks prior to the intervention.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Placebo komparator: Control group
Placebo dry needling
|
Placebo dry needling will be performed with DongBang DB100 Acupuncture Needles which, upon contact with the patient, retract, hiding in the needle handle.
The patient will be in the prone position with a pillow in the abdominal region.
The area will be cleaned with an antiseptic and allowed to air dry for 3 minutes.
At the point indicated by the evaluator, the placebo needle will be placed initially and the introduction of the needle and its location will be simulated with the ultrasound system.
10 repetitions will be performed.
The needle will be removed by depositing it in a needle container and a compression will be made in the treated area.
|
Eksperimentell: Experimental group
Dry needling
|
The dry needling will be performed using disposable stainless steel needles (AGU-PUNT needles of size 0.30x50mm or 0.30x60mm depending on the patient) that will be inserted perpendicularly at the point of major hyperalgesia using the Hong technique.
The patient will be in the prone position with a pillow placed in the abdominal region.
The area will be cleaned with an antiseptic and allowed to air dry for 3 minutes.
After this time, the needle will be inserted at the point indicated by the evaluator before reaching the lumbar multifidus by means of echolocation.
Once it is assured that it is in the right place, a total of 10 repetitions are performed.
The needle will be removed by depositing it in a needle container and a compression will be removed in the treated area until hemostasis is achieved.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Changes from baseline in pain on the 10-point Visual Analog Scale (VAS, 0-10 score) at immediatelypost-needling and a week after.
Tidsramme: Baseline, immediately post-needling and a week after.
|
This scale shows concurrent and predictive validity in the assessment of pain.
A difference of 2 points represents a clinically significant change that exceeds the limits of measurement error.
|
Baseline, immediately post-needling and a week after.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Thickness of lumbar multifidus measured with Rehabilitive Ultrasound Imaging in millimeters
Tidsramme: Baseline, immediately post-needling and a week after.
|
Baseline, immediately post-needling and a week after.
|
|
Histograms using image analysis
Tidsramme: Baseline, immediately post-needling and a week after.
|
Baseline, immediately post-needling and a week after.
|
|
Pressure Pain threshold
Tidsramme: Baseline, immediately post-needling and a week after.
|
It will be measured by using a pressure algometer.
Lumbar multifidus algometry is performed approximately 1.5 cm from the spinous process of the level to be evaluated.
The measurement will be taken 3 times to avoid variability by instructing patients to say verbally when they begin to feel pain.
|
Baseline, immediately post-needling and a week after.
|
Disability
Tidsramme: Baseline, immediately post-needling and a week after.
|
it will be measured using the Roland-Morris questionnaire.
Values range from 0 (absence of disability) to 24 (maximum level of disability).
|
Baseline, immediately post-needling and a week after.
|
Contraction time measured in milliseconds with M-mode
Tidsramme: Baseline, immediately post-needling and a week after.
|
The patient performs a hip extension in the prone position
|
Baseline, immediately post-needling and a week after.
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 210108
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Smerte i korsryggen
-
Otsuka Pharmaceutical Co., Ltd.Aktiv, ikke rekrutterendeHyper-low-density Lipoprotein (LDL) KolesterolemiJapan
-
Bozok UniversityFullført
-
Health Services Academy, Islamabad, PakistanUkjentmHelse | Gjeninnleggelse | Teach-back kommunikasjonPakistan
-
Rush University Medical CenterFullførtPasientutdanning | Teach-back kommunikasjon | Etter besøksinstruksjoner | PasientforståelseForente stater
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinAktiv, ikke rekrutterendeSimulering av fysisk sykdom | Trakeostomikomplikasjon | Teach-back kommunikasjonForente stater
-
Otsuka Pharmaceutical Co., Ltd.FullførtHyper-low-density Lipoprotein (LDL) KolesterolemiJapan
-
Marmara UniversityAktiv, ikke rekrutterendeTeach-back kommunikasjonTyrkia
-
Jordan Collaborating Cardiology GroupThe Cardiovascular Academy Group of the JCS; The Jordan Cardiac Society... og andre samarbeidspartnereAvsluttetAterosklerotisk kardiovaskulær risiko | Low-density-lipoprotein (LDL) kolesterolJordan
-
University of ValenciaFullført
-
Nina HermansUniversity Hospital, AntwerpRekrutteringLow-density-lipoprotein-type [LDL] HyperlipoproteinemiBelgia
Kliniske studier på Placebo dry needling
-
Iran University of Medical SciencesHar ikke rekruttert ennåEpisodisk spenningshodepine
-
Iran University of Medical SciencesRekrutteringSmerte i korsryggenIran, den islamske republikken
-
Brigham Young UniversityAvsluttetMyofascial smertesyndrom | Myofascial triggerpunktsmerteForente stater
-
Universidad Rey Juan CarlosFullført
-
University of Kansas Medical CenterHar ikke rekruttert ennå
-
Universidad de ZaragozaFullført
-
Institute of Technology, CarlowFullført
-
Universidad de ZaragozaUkjent
-
Universitat Internacional de CatalunyaRekrutteringMyofascial triggerpunktsmerteSpania
-
University of HaifaFullførtSmerte i korsryggenIsrael